Table 1 Comparison of demographic and clinical characteristics of the 70 patients grouped by 6-month primary patency
Group Aa (n = 54) | Group Bb (n = 16) | p | |
|---|---|---|---|
Man, n (%) | 39(72.2) | 15(93.8) | 0.074 |
Age, mean (SD) | 65.52(10.55) | 68.38(8.46) | 0.325 |
Hypertension, n (%) | 37(68.5) | 12(75.0) | 0.622 |
Smoke, n (%) | 42(77.8) | 10(62.5) | 0.223 |
Diabetes, n (%) | 29(53.7) | 12(75.0) | 0.132 |
Hyperlipemia, n (%) | 13(24.1) | 5(31.3) | 0.567 |
Cardiovascular disease, n (%) | 21(38.9) | 10(62.5) | 0.097 |
Severe calcium, n (%) | 5(9.3) | 1(6.3) | 1.000 |
CLI, n (%) | 20(37.0) | 10(62.5) | 0.073 |
Total occlusion, n (%) | 38(70.4) | 11(68.8) | 0.902 |
Outflow, n (%) | |||
1 | 10(18.5) | 7(43.8) | |
2 | 14(25.9) | 3(18.8) | 0.087 |
3 | 30(55.6) | 6(37.5) | |
Bail-out stent, n (%) | 6(11.1) | 2(12.5) | 0.879 |
Lesion length > 10 cm, n (%) | 20(37.0) | 12(75.0) | 0.008 |
WBC, median (IQR) | 6.86(5.86–9.18) | 6.62(5.01–9.34) | 0.727 |
Platelets, mean (SD) | 203.39(65.56) | 249.13(75.45) | 0.021 |
MPV, median (IQR) | 9.00(8.37–9.80) | 8.45(8.00–8.90) | 0.070 |
Neutrophils, median (IQR) | 4.35(3.6–6.0) | 3.65(2.85–6.82) | 0.511 |
Lymphocytes, median (IQR) | 1.95(1.57–2.60) | 1.50(1.20–1.78) | 0.001 |
Pre-NLR, median (IQR) | 2.14(1.70–2.78) | 3.29(1.85–4.32) | 0.055 |
Pre-PLR, median (IQR) | 94.11(67.99–125.48) | 187.29(131.67–212.86) | <0.001 |